CCMH
KITE

Cornerstone Capital Management Holdings’s Kite Pharma, Inc. KITE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,303
Closed -$3.29M – 1394
2017
Q3 		$3.29M Sell
18,303
-800
-4% -$111K 0.03% 577
2017
Q2 		$1.98M Buy
19,103
+1,310
+7% +$107K 0.02% 728
2017
Q1 		$1.4M Buy
17,793
+11,228
+171% +$694K 0.01% 845
2016
Q4 		$294K Sell
6,565
-1,500
-19% -$73.6K ﹤0.01% 1153
2016
Q3 		$450K Buy
8,065
+3,300
+69% +$184K ﹤0.01% 1091
2016
Q2 		$238K Buy
4,765
+2,300
+93% +$113K ﹤0.01% 1173
2016
Q1 		$113K Sell
2,465
-300
-11% -$14.5K ﹤0.01% 1303
2015
Q4 		$170K Buy
2,765
+265
+11% +$18.7K ﹤0.01% 1233
2015
Q3 		$139K Buy
2,500
+500
+25% +$31.4K ﹤0.01% 1284
2015
Q2 		$122K Buy
+2,000
New +$114K ﹤0.01% 1281

Cornerstone Capital Management Holdings's KITE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 18,303 shares — an estimated $3.29M sold.

Cornerstone Capital Management Holdings first reported a position in KITE in Q2 2015 and held it in 10 quarters. The position peaked at $3.29M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Cornerstone Capital Management Holdings reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 18,303 Kite Pharma, Inc. shares in Q4 2017, an estimated $3.29M.
  • Cornerstone Capital Management Holdings first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 10 quarters.
  • Cornerstone Capital Management Holdings's Kite Pharma, Inc. position peaked at $3.29M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.